The 5-HT1A agonist 8-OH-DPAT increases the number of spike-wave discharges in a genetic rat model of absence epilepsy
- 1 October 1998
- journal article
- Published by Elsevier in Brain Research
- Vol. 807 (1-2) , 243-245
- https://doi.org/10.1016/s0006-8993(98)00801-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparison of relative potencies of i.v. and i.c.v. administered 8-OH-DPAT gives evidence of different sites of action for hypothermia, lower lip retraction and tail flicksEuropean Journal of Pharmacology, 1997
- Modulation of rat neocortical high-voltage spindle activity by receptor subtype specific drugsEuropean Journal of Pharmacology, 1995
- Basic mechanisms of generalized absence seizuresAnnals of Neurology, 1995
- Calcium‐Dependent Regulation of Genetically Determined Spike and Waves by the Reticular Thalamic Nucleus of RatsEpilepsia, 1993
- Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of ratsEpilepsy Research, 1992
- Serotoninergic innervation of the thalamus in the primate: An immunohistochemical studyJournal of Comparative Neurology, 1991
- Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain — a combined in situ hybridisation/in vitro receptor autoradiographic studyBrain Research, 1991
- Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation currentNature, 1989
- Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsyNeuroscience Letters, 1985
- Cortically elicited spike-wave afterdischarges in thalamic neuronsElectroencephalography and Clinical Neurophysiology, 1976